This educational talk provides a broad overview of gadolinium based contrast agents (GBCA) for MRI with a focus on the types of gadolinium chelators, toxicity concerns with a focus on nephrogenic systemic fibrosis (NSF), as well as potential applications for specific GBCA. Although numerous MRI contrast agents have been developed, this talk will focus on those that are clinically available to inform radiologists of potential clinical applications for GBCA.
This abstract and the presentation materials are available to members only; a login is required.